J Biol Chem, Vol. 275, Issue 8, 5927-5933, February 25, 2000
Induction of Light Chain Replacement in Human Plasma Cells by
Caffeine Is Independent from Both the Upregulation of RAG Protein
Expression and Germ Line Transcription*
Hirofumi
Tachibana
,
Hirotaka
Haruta,
Kyoko
Ueda,
Takanori
Chiwata, and
Koji
Yamada
From the Division of Bioresources and Bioenvironmental Science,
Graduate School, Kyushu University, Hakozaki 6-10-1, Higashi-ku,
Fukuoka, 812-8581, Japan
 |
ABSTRACT |
When some human plasma cell lines are cultured
with concanavalin A, the original light chain is replaced with another
light chain which results from secondary VJ recombination (light chain shifting). We examined various intracellular factors involved in the
induction of light chain shifting. Light chain shifting can be induced
upon treatment with agents with phosphatase inhibitory activity such as
caffeine and okadaic acid. Although the plasma cells used express both
RAG-1 and RAG-2, the expression level of these proteins was not
affected by caffeine or okadaic acid. Transcription of the germ line
locus, which correlates to the locus activation for rearrangement, is
also not influenced by phosphatase inhibition. However, the amount of
signal broken-ended DNA intermediates generated during V(D)J
rearrangement was shown to increase upon caffeine or okadaic acid
treatment. The inhibitory activity of caffeine on phosphatase was the
same as okadaic acid. However, caffeine exhibited much higher activity
for VJ coding joint formation than okadaic acid. Therefore, although
phosphatase inhibition might act, in part, on a mechanism by which
V(D)J recombinase activity is regulated within the human plasma cells,
other factor(s) are probably also involved in the process.
 |
INTRODUCTION |
Immunoglobulin genes are assembled during B cell development
through a series of site-specific recombination events collectively termed V(D)J recombination (1). The V(D)J recombination reaction is
initiated by the recombination activating gene products RAG-1 and RAG-2
and is completed by a set of proteins employed in most cell types for
DNA double-stranded break repair such as the Ku-80 antigen, a large
catalytic subunit of DNA-dependent protein kinase and XRCC4
(2-6). Although many of the VJ recombinations at the light chain loci
occur in pre-B cells, recent findings suggest that light
chain gene rearrangements often continue in immature-B cells and
germinal center B cells (7-11). We also have shown that secondary VJ
recombination can occur in some human plasma cell lines when stimulated
with concanavalin A (ConA)1
(12, 13). We call this process light chain shifting (14).
Several factors have been shown to be involved in Ig gene rearrangement
in terms of timing and placement (1). V(D)J recombinase activity is
determined by the regulated expression of RAG-1 and RAG-2 (3). These
genes are expressed only when B cells rearrange the Ig heavy and light
chain loci. The RAG gene products are necessary for Ig recombination,
and coexpression of these two genes in nonlymphoid cells is sufficient
to confer the ability to recombine artificial plasmid substrates (15).
Secondary VJ rearrangements in immature B cells and our plasma B cells
are closely correlated with coexpression of the two RAG genes (10, 14).
However, there must be additional levels of regulation to determine
which loci are targeted for recombination in developing lymphocytes,
because endogenous Ig genes are only targeted for complete
rearrangement in B lineage cells, and endogenous T cell receptor genes
are only completely rearranged in T lineage cells. Plus we have also
found that enhancement of RAG expression is not sufficient to induce
secondary VJ rearrangement in light chain shifting-inducible human
plasma cells (13, 14). Therefore, expression of RAG-1 and RAG-2 is
likely to be only part of the mechanism by which V(D)J recombination is
activated in lymphoid cells. In lymphoid cells, specific developmental
signals result in changes in the chromatin that allows the recombinase access to particular gene segments (16, 17). Results showing that
activation of a locus for rearrangement correlates with the transcription of that particular germ line locus support the
accessibility hypothesis (18-20).
In this report, we investigated various intracellular factors that may
induce light chain shifting in human plasma cells. We found that the
RAG gene products and the transcription of the germ line locus is not
sufficient to carry out secondary VJ recombination in human plasma
cells. However, phosphatase inhibition by caffeine or okadaic acid was
found to be necessary to induce secondary VJ recombination. The
phosphatase inhibition induced the formation of signal broken-ended DNA
intermediates in the cells, which is an initial step in the V(D)J
recombination process.
 |
MATERIALS AND METHODS |
Reagents--
Caffeine, dibutyryl cAMP (DbcAMP), forskolin,
ionomycin, H-89, H-7, phorbol myristate acetate (PMA), were obtained
from Sigma. Okadaic acid and sodium orthovanadate (vanadate) were
purchased from Wako (Osaka, Japan).
Cells and Cell Stimulation--
Fusing a B lymphocyte with the
IgM secreting human plasma line NAT-30 (21, 22) generated the human
hybridoma cell line HB4C5, which secretes a monoclonal antibody
specific to the human histone H2B. For cell stimulation, cells (1 × 106 cells/ml) were cultured in the presence of caffeine
(2 mM), DbcAMP (50 ng/ml), forskolin (100 µM), ionomycin (250 ng/ml), H-89 (20 µM),
H-7 (100 µM), PMA (50 ng/ml), okadaic acid (1, 10, or 100 nM), or vanadate (100 µM).
Protein Phosphatase Activity Assay--
The protein phosphatase
activity in inhibitor-treated cells was assayed using a
serine/threonine protein phosphatase assay kit from Upstate
Biotechnology according to the manufacturer's instruction. The cells
were incubated with caffeine (2 mM), okadaic acid (1 and
100 nM), or vanadate (100 µM) for 24 h
in cell culture dishes. At the end of the incubation period, 1 × 106 cells were transferred into Eppendorf tubes, washed
with 50 mM Tris/HCl, pH 7.0, and the cells were lysed in 1 ml of extraction buffer (50 mM Tris/HCl, pH 7.0, 0.1%
2-mercaptoethanol, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM phenylmethylsufonyl fluoride, 0.5% Triton X-100). The
lysate was spun down at centrifuged for 5 min at 10,000 × g at 4° C, and then the supernatant was recovered. 20 µl of the supernatant was mixed with 5 µl of 1 mM
phosphatase substrate (phosphopeptide; K-R-pT-I-R-R), the mixture was
incubated for 60 min at 37 °C. 100 µl of Malachite Green solution
was added to the mixture to terminate the enzyme reaction, and then the mixture was incubated at room temperature for 15 min to allow color
development. Absorbance at 650 nm was measured, and phosphatase activity was calculated by comparing the absorbance to the phosphate standard curve.
Western Blot Analysis of RAG and
Light Chain
Expression--
Cells were collected, washed once in
phosphate-buffered saline, lysed in 60 mM Tris/HCl, pH 7.6, 1% SDS, and boiled for 5 min. Protein concentration was determined
using the Bio-Rad protein assay kit, and lysates (600 µg/sample) were
electrophoresed on SDS-polyacrylamide gels (10%) and then transferred
to a nitrocellulose membrane. The blotted RAG proteins were detected by
immunoblotting with 1 µg/ml of anti human RAG-1 or RAG-2 antibodies
(Pharmingen, San Diego, CA). Immunoreactive proteins were detected by
incubation with horseradish peroxidase-conjugated goat anti mouse IgG
antibody (Sigma) at a 1:2000 dilution for 1 h at room temperature;
immobilized horseradish peroxidase was visualized using an enhanced
chemiluminescence assay (Amersham Pharmacia Biotech). To detect the
human
light chain, the blotted membrane was incubated in a 1:500
dilution of horseradish peroxidase-conjugated goat anti-human
light
chain antibody (BIOSOURCE) for 1 h. The
membranes were washed in phosphate-buffered saline containing 0.05%
Tween 20 and developed with 1.6 mM 4-chloro-1-naphthol, 0.01% H2O2 in phosphate-buffered saline with
20% methanol.
RT-PCR and Nucleotide Sequence Analysis--
Total RNA, prepared
using the TRIzol reagent (Life Technologies, Inc.), was reversed
transcribed, and the resultant cDNA served as a template for PCR
amplification using specific primers. cDNA was synthesized from
total RNA using a kit (Amersham Pharmacia Biotech) according to the
instructions provided by the manufacturer. To synthesize the cDNA
from the V
6 germ line transcript, 20 pmol each of
P-V
CA3GTR (5'-GGAGTTTCTGTCTCACTTCC-3') and P-G3PDR
(5'-GGATGATGTTCTGGAGAGCC-3') were used for reverse transcription. Glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH) amplification was
carried out and used as a control standard. As a negative control,
mRNA samples that were not reverse-transcribed also served as
templates for PCR amplification. PCR was done in 50-µl reaction volumes containing 10 mM Tris/HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 20 µg/ml
gelatin, 1 µM of each primer, 0.2 mM of each
dNTP, and 1 unit of Taq polymerase (Fermentas, Lithuania).
Samples were predenatured at 94 °C for 2 min followed by
amplification at 96 °C for 20 s, 60 °C for 1 min, and
72 °C for 1 min followed by a final 10-min extension step at
72 °C. The number of cycles for amplification of the variable region
of
chain, GAPDH gene, or V
6 germ line transcript was
20, 10, or 12, respectively. The PCR primers used were as follows. The
V regions of the
light chain genes (23): P-LLF,
5'-ACTAGAATTCATG(AG)CCTG(CG)(AT)C(CT)CCTCTC(CT)T(CT)CT(CG)(AT)(CT)CC-3'; P-LLR, 5'-ACTAGCGGCCGCCTATGAACATTC(CT)G(CT)AGGGGC-3'; GAPDH, P-GAPDF, 5'-CATCACCATCTTCCAGGAGC-3'; and P-GAPDR, 5'-GGATGATGTTCTGGAGAGCC-3'. The nucleotide sequences of the V region were determined, after subcloning into the pGEM-T vector (Promega), using the DyeDeoxy terminator kit (Perkin-Elmer) with the DNA sequencer ABI 310 (Perkin-Elmer) according to the manufacturer's instruction.
DNA Analysis--
Genomic DNA was prepared as described
previously (19). The PCR was performed to detect the
V
C5-to-J
coding joint for the original
light chain
C5 or the V
J
coding joints for the new
light chains (FF1, FF2, and FF3). The following primers were used: V
4P (V
4-CDR1
region-specific) 5'-CTCTGAGCAGTGGGCACAGC-3' (sense), V
6P
(V
6-CDR1 region-specific) 5'-AGTTGCAGCATTTTCAGCAAC-3' (sense), and J
P (conserved 3' of J
)
5'-TCAGTTTAGTCCCTCCGCC-3' (antisense). PCR reactions were done as
described above for RT-PCR. Aliquots were withdrawn at cycles 20 and 25 for separate analysis to ensure that amplification was within a linear
range. Reaction products were run on 0.8% agarose gels, followed by
Southern blot hybridization. The PCR products were transferred onto
nylon transfer membranes (Hybond-N+, Amersham Pharmacia
Biotech), and hybridized with fluorescein-labeled probes. cDNA
fragments coding for each
light chain, which were used for
analyzing the variable region sequence, was digested from their
respective vectors with restriction enzymes. The resulting fragment,
each containing the specific V gene, was labeled using the
oligonucleotide labeling kit (Gene Images, Amersham Pharmacia Biotech)
for use as probes for the detection of the corresponding V
J
coding joints. To check for possible
Taq polymerase errors, all PCR products were sequenced and
compared with previously defined sequences.
LMPCR Assay for Detecting Signal DNA Broken Ends (SBE)--
The
LMPCR assays for detecting signal end breaks, as have been described by
Schlissel et al. (24), was performed with minor modifications. The BW linker was made by annealing the oligonucleotides BW-1 (5'-GCGGTGACCCGGGAGATCTGAATTC-3') and BW-2 (5'-GAATTCAGATC-3'). 2 µg of genomic DNA extracted as described above were ligated with 20 pmol of the BW linker in a reaction volume of 20 µl using 3 units of
T4 DNA ligase (Promega). The same reaction mixtures without the BW
linker were also prepared as negative controls. After an overnight
incubation at 4 °C, the ligation reaction was stopped by incubating
samples at 95 °C for 10 min. Hot start PCR amplification was
performed in a 10-µl reaction volume using 0.5 unit of Taq
DNA polymerase (AmpliTaq Gold, Perkin Elmer), 10 pmol each of the sense
direction primer BW-1 and the antisense direction primer
P-V
6SBER (5'-CTTAGTAGCTGAAGACATGC-3'), and 1 µl of serially diluted linker-ligated templates. Samples were predenatured at
95 °C for 9 min followed by 35 cycles of 96 °C for 20 s,
62 °C for 10 s, and 72 °C for 30 s followed by a final
7-min extension step at 72 °C. After amplification, bands for
V
6 SBE were detected by Southern hybridization. Blots
were visualized using the fluorescein-labeled locus-specific internal
probe P-V
CA3GTR.
 |
RESULTS |
Induction of New
Light Chain Production in the Plasma B Cell
Line HB4C5 by Caffeine Stimulation--
We previously found that ConA
simulation can induce light chain replacement in the human plasma cell
line HB4C5, which is known to secrete IgM reactive to the human histone
H2B (22). This lectin is known to have a multitude of effects in
mammalian systems (25, 26). To elucidate which intracellular factors are involved in the light chain shifting, we tested various agents that
affect second messenger pathways for their influence on new light chain
production in the HB4C5 cells. The HB4C5 cells were cultured in medium
containing caffeine, DbcAMP, forskolin, ionomycin, H-89, H-7, or PMA
for 2 weeks. Then, the culture supernatants were analyzed for the
secretion of
light chains by immunoblotting (Fig.
1). Among the compounds that increase
intracellular cAMP concentration, caffeine, DbcAMP, and forskolin, only
caffeine was shown to be able to induce the expression of a new
light chain. Furthermore, H-89 and H-7 (inhibitors of serine/threonine protein kinase), ionomycin (known to increase free cytosolic calcium concentration), and PMA (known to stimulate protein kinase C) failed to
induce the production of a new light chain. These results suggest that
induction of the new
light chain by ConA can be mimicked by
treatment with caffeine, whereas several other known factors that
affect second messenger pathways cannot.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
Induction of new light chain production in the human plasma cell line HB4C5 by
caffeine stimulation. Culture supernatants from HB4C5 cells
cultured for 2 weeks in the presence of caffeine (2 mM),
DbcAMP (50 ng/ml), forskolin (100 µM), ionomycin (250 ng/ml), H-89 (20 µM), H-7 (100 µM), or PMA
(50 ng/ml) were analyzed for the secretion of light chains by
immunoblotting.
|
|
To confirm that the caffeine-induced new light chain production is a
result from light chain shifting, we subcloned the caffeine-treated cells. One of the feature of light chain shifting is that new light
chain-secreting subclones produce only one new light chain replacing
the originally expressed light chain. Culture supernatants from 68 subclones, which were cloned by limiting dilution, were selected
randomly from caffeine-treated HB4C5 cells and subjected to
SDS-polyacrylamide gel electrophoresis and transferred to
nitrocellulose, and
light chains were detected using an anti human
light chain antibody (Fig. 2).
Secretion of the various new
light chains, which are determined by
their difference in size from the original (32 kDa), was observed in 8 wells (Fig. 2, lanes 7, 34, 35,
36, 40, 49, 56, and
57). Three independent subclones (FF1, FF2, and FF3) that
were shown to secrete not the original
chain but only a new
chain were selected, and nucleotide sequences of the variable regions
of these expressed light chains were analyzed (Fig.
3). Sequences were compared with the
corresponding germ line V
(HUMIGL8V and HSIGLV36). The
germ line V
gene of the original
light chain (
C5)
has been shown to belong to V
1 family, as grouped by
Chuchana et al. (27). The germ line V
families used in the light chain genes from the three subclones were
shown to be V
4 and V
6. Strikingly, these
V
gene families are the least frequently used (28).
Although FF2 and FF3 express genes encoded by the same germ line
V
gene (HSIGLV36), they apparently originated from
independent recombination events, as judged by having distinct VJ
joining sequences. This was confirmed by a genomic DNA analysis using
V
family-specific probes (Fig.
4). The same expression pattern for new
light chains was also found in ConA-induced light chain shifting,
suggesting that caffeine stimulation does indeed induce the light chain
shifting.

View larger version (64K):
[in this window]
[in a new window]
|
Fig. 2.
Immunoblot analysis of secretion of a new
light chain replacing the originally expressed light chain from
caffeine-treated cells. Culture supernatants from 68 subclones,
which were cloned by limiting dilution, were selected randomly from
caffeine-treated HB4C5 cells, subjected to SDS-polyacrylamide gel
electrophoresis, and transferred to nitrocellulose, and light
chains were detected using an anti human light chain
antibody/horseradish peroxidase conjugate.
|
|

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 3.
Nucleotide sequences of the variable regions
for the new light chains expressed in light
chain-shifted subclones. Nucleotide sequences of the variable
regions for the light chains expressed in the three HB4C5 subclones
(FF1, FF2, and FF3) are shown in a 5' to 3' direction.
VLFF1, VLFF2, and VLFF3 represent the
light chain genes expressed by these subclones. Sequences were
compared with the corresponding germ line V (HUMIGL8Vand
HSIGLV36) and J 2/3 sequences. Designations in
brackets indicate their corresponding V gene
family. Dashes indicate homology with the germ line genes.
Dots indicate where gaps have been introduced to maximize
homology.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 4.
Expression of new light chains induced by
caffeine is a result of secondary VJ rearrangements. a,
a diagram of the PCR primers used to detect the VJ coding joint. The
directions of primers used are indicated with arrowheads.
b, genomic DNA from HB4C5 cells and the new light
chain-expressing subclones FF1, FF2, and FF3 were analyzed for
secondary VJ rearrangement by PCR. The PCR amplified products were
detected with the V 4- and V 6-specific
probes. Bands corresponding to the VJ coding joint for
V 4 joined to J and V 6
jointed to J are shown. c, genomic DNA from HB4C5 cells
treated with caffeine (2 mM), DbcAMP (50 ng/ml), forskolin
(100 µM), ionomycin (250 ng/ml), H-89 (20 µM), H-7 (100 µM), PMA (50 ng/ml), or PMA
(50 ng/ml) + ionomycin (250 ng/ml) were also analyzed for secondary
V 6-J rearrangement.
|
|
Caffeine-stimulated New Light Chain Expression Is a Result of
Secondary VJ Rearrangements--
To determined whether the new light
chain expression stimulated by caffeine results from secondary
recombination, we analyzed V
J
gene
rearrangements in the new light chain-expressing subclones, FF1, FF2,
and FF3. Genomic DNA from HB4C5 cells and the FF1, FF2, and FF3
subclones was subjected to PCR to detect for the presence of a
V
J
coding joint formation specific for
the new light chain using primers corresponding to the
V
4 and V
6 families. The products were
analyzed by Southern blot hybridization. A diagram of the PCR assay is
shown in Fig. 4a. PCR product was detected only in the DNA
from the new light chain-producing subclones, suggesting that the new
VJ rearrangements occurred during the cell stimulation with caffeine
(Fig. 4b). In Fig. 1, we tested various agents for their
ability to secrete a new light chain and found that only caffeine could
stimulate new light chain production. We tested the same agents for
their ability to induce secondary VJ recombination by PCR using the
V
6P and J
P primers. Only caffeine
activated the secondary VJ recombination (Fig. 4c), which
supports the results in Fig. 1. These genetic events in the
caffeine-stimulated new light chain-producing cells exactly match the
results shown for ConA-stimulated cells, suggesting that caffeine does
mimic the effect of ConA stimulation on the light chain shifting.
Caffeine-induced Secondary VJ Recombination in Plasma Cells Depends
on Phosphatase Inhibitory Activity--
Caffeine exerts a multitude of
effects in mammalian cells including DNA intercalation and inhibition
of protein serine/threonine phosphatase and cAMP phosphodiesterase
(29-31). As shown previously, with the exception of caffeine, agents
that increase intracellular cAMP could not induce light chain shifting.
Interestingly, HB4C5 cells costimulated with caffeine and DbcAMP did
not express any new light chains (data not shown). Thus, effects other
than the increasing of cAMP are thought to be responsible for the
induction of the light chain shifting by caffeine.
To test the possibility that the effect of caffeine on light chain
shifting is due to serine/threonine protein phosphatase inhibitory
activity, HB4C5 cells were treated with okadaic acid, which is a
serine/threonine phosphatase inhibitor (32), or vanadate, which is an
inhibitor of dual specificity phosphatase and tyrosine phosphatase
(33). Genomic DNA was analyzed for the formation of a VJ coding joint
by PCR, as described in the legend to Fig. 4. We focused on the
V
6-to-J
coding joint formation because it
is the most frequently used V
segment in light chain
shifting. As shown in Fig. 5a,
stimulation of HB4C5 cells with okadaic acid at a concentration of 100 nM for 96 h induced the formation of a
V
6-to-J
coding joint. Similar induction levels of the VJ recombination was obtained even at lower
concentrations (10 and 1 nM). In contrast, a concentration
of 100 µM vanadate was less efficient for the induction
of VJ recombination. To determine the inhibitory effects of these
agents on the serine/threonine protein phosphatase in HB4C5 cells, the
phosphatase activity in the cells treated with either the agent or
caffeine was measured (Fig. 5b). Caffeine treatment
decreased serine/threonine phosphatase activity by 10%. Treatment with
okadaic acid or vanadate also caused a 10-20% loss of the phosphatase
activity. Therefore, the induction of light chain shifting may be
brought about, in part, by the inhibition of serine/threonine protein
phosphatase. However, the level of VJ coding joint formation by
caffeine was much higher than that by okadaic acid and vanadate.
Therefore, other factor(s) may be involved in the process.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 5.
Induction of secondary VJ recombination in
the plasma cell line HB4C5 by phosphatase inhibitors.
a, genomic DNA was analyzed for secondary VJ rearrangement
by PCR. A diagram of the PCR primers used to detect the formation of
new VJ coding joint is shown in Fig. 4a. PCR was performed
using primers that amplify the V 6-J
coding joint formation with diluted (100 and 10 ng) total genomic DNA
taken from HB4C5 cells treated with caffeine (2 mM),
okadaic acid (1, 10, 100 nM), or vanadate (100 µM) for 96 h. The PCR amplified products were
detected using the V 6-specific probe by Southern
blotting. GAPDH gene amplification was simultaneously performed as a
DNA loading control. b, the cells were treated with caffeine
(2 mM), okadaic acid (1 nM, 100 nM), or vanadate (100 µM) for 24 h. The
serine/threonine protein phosphatase activity was detected as described
under "Materials and Methods" and expressed as a percentage of the
control level (assuming the sample obtained from the nontreated cells
has an activity of 100%).
|
|
RAG Protein Expression and Germ Line
Gene Transcription Are Not
Enhanced by Caffeine or Okadaic Acid--
RAG-1 and RAG-2 gene
products have been shown to be essential for initiating Ig gene
rearrangement, and the levels of the RAG proteins have been known to be
affected with cell proliferation (2, 24). Both proteins were expressed
in the HB4C5 cells (13). To elucidate the mechanism that couples
phosphatase inhibition and light chain shifting, we evaluated the
expression of RAG genes in the HB4C5 cells. The level of RAG proteins
expressed was not affected by the stimulation of either caffeine or
okadaic acid at the concentration sufficient for inducing light chain
shifting (Fig. 6). We also found no
differences in the growth rates and viability of the cells stimulated
with or without these agents (data not shown). Thus, the induction of
light chain shifting by these agents seems to be independent from the
enhancement of RAG gene expression.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 6.
Induction of secondary VJ rearrangement by
phosphatase inhibitors does not result from an enhancement of RAG
protein expression. Cells were stimulated with the indicated
stimuli for 24 and 96 h (unstimulated control, 2 mM
caffeine, 1 nM okadaic acid). Cells were lysed in SDS lysis
buffer. 600 µg protein/lane from each sample was fractionated by 10%
SDS-polyacrylamide gel electrophoresis, and the expression of RAG-1 and
RAG-2 proteins was assessed by immunoblotting.
|
|
It has been shown that genes undergoing V(D)J recombination are
transcribed coincident with or before their rearrangement (34), and an
increase in the production of the germ line transcript is associated
with gene rearrangement (35). These observations have led to the
hypothesis that stimuli by caffeine or okadaic acid can induce light
chain shifting via an enhancement of germ line transcription. Because
the V
6 locus is frequently used in light chain shifting,
we used the unrearranged V
6 locus as a model
V
gene segment to test this possibility (14). RT-PCR
used to detect and quantify the amount of transcript produced. We found
that the HB4C5 cells could transcribe the germ line V
6 locus at any of the given time points tested (Fig.
7). The steady-state levels of the
transcript did not changed upon treatment with caffeine or okadaic acid
for 3, 6, 24, and 96 h (Fig. 7, b and c). These results
indicate that incubation with the phosphatase inhibitors do not affect
the germ line transcription in HB4C5 cells. The failure to observe an
increase in germ line gene transcription as well as RAG protein
expression, both of which are known to parallel the increase in
frequency of V(D)J recombination, leads us to suggest that other
factor(s) may be involved when light chain shifting is induced upon
stimulation with caffeine or okadaic acid.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 7.
Detection of the
V germ line transcript in HB4C5
cells treated with phosphatase inhibitors. a, schematic
diagram of the V 6 390-bp RT-PCR product. b
and c, V 6 germ line and GAPDH gene
transcripts were evaluated by quantitative RT-PCR followed by Southern
blotting. RNA isolated from the cells treated as indicated (2 mM caffeine or 1 nM okadaic acid) for 0, 3, 6, or 24 h (b) and 96 h (c) was assayed.
Serially diluted (50, 5, or 0.5 ng of total RNA equivalent) cDNA
were used as templates in this assay. The same samples were also used
as templates for amplification of GAPDH followed by Southern
hybridization as a DNA loading control. As a negative control, mRNA
samples (100 ng of total RNA equivalent) were isolated from cells
treated with either caffeine or okadaic acid for 24 h. These
non-reverse-transcribed samples were used as templates for PCR
(indicated as -RT). The arrows indicate the
expected size for each PCR product.
|
|
The Amount of Signal Broken Ends Derived from the Initiation of
Chain Gene Rearrangement Is Increased by Phosphatase
Inhibition--
V(D)J recombination is initiated by a precise cleavage
at the junction between a coding gene and a flanking recombination signal sequence to generate two broken-ended species, a signal end, and
a coding end (cutting phase). The signal ends and coding ends are
subsequently joined to generate signal joints and coding joints
(joining phase) (36). We investigated whether the two phases are
enhanced upon stimulation with the phosphatase inhibitors. SBE are in a
blunt-ended conformation until they are joined, and this broken-ended
species is joined before the onset of DNA synthesis (24, 37). Thus, in
cycling cells, SBE can be a reliable measure of VJ recombinase
activity. If the cutting phase of V(D)J recombination is activated by
stimulation with caffeine or okadaic acid, the amount of SBE produced
might increase (38). Genomic DNA prepared from HB4C5 cells stimulated
with one of the phosphatase inhibitors for 24 and 96 h was assayed
for SBE using LMPCR (24). DNA were subjected to ligation with a
double-stranded linker capable of ligating in only one orientation.
Linker-ligated DNA was then used as template for amplification by PCR
using a linker-specific primer and a locus-specific primer (Fig.
8a). The same experiment using
independently prepared genomic DNA samples were performed several
times, and a representative result is shown. HB4C5 cells after
cultivation with caffeine or okadaic acid for 96 h contain a
definitely higher level of V
6 SBE compared with
unstimulated cells (Fig. 8c), whereas the SBE signal was
barely detected in the DNA obtained from the cells treated with these
agents for 24 h (Fig. 8b). These results shows that at
least early steps in the V
-J
recombination are enhanced in HB4C5 cells stimulated by agents with
phosphatase inhibitory activity.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 8.
LMPCR analysis of signal end double-stranded
DNA breaks in
V J
recombination. a, diagram of the LMPCR assay used
to detect signal end double-stranded DNA breaks on the rearranging
loci. A pair of annealed oligonucleotides (thick bar) is
ligated to signal end present in DNA prepared from the cells. PCR was
performed using appropriate primers (BW1 and P-V 6 SBER).
b and c, genomic DNA, extracted from HB4C5 cells
cultured with the stimuli indicated above each lane for 24 h
(b) and 96 h (c) were ligated with
(linker (+)) or without (linker ( )) the BW
linker, and were subjected to PCR to detect SBE. 100 and 10 ng of
genomic DNA equivalent samples ligated with the BW linker were prepared
and used as templates. PCR products were probed with an internal
locus-specific oligonucleotide probe (P-V CA3GTR).
Bands for V 6 SBE were expected to be 497 bp
in length, and the positions are indicated by the arrows.
GAPDH gene amplification followed by Southern hybridization using the
same samples for detection of V 6 SBE was simultaneously
performed as a DNA loading control.
|
|
 |
DISCUSSION |
We have previously found that the
light chain replacement from
an original to a novel chain can be induced in some human plasma cells
by ConA stimulation (12, 13). We call this process light chain
shifting. This finding is in contrast to reports stating that
continuous novel light chain expression can occur in some sIg+ B cells in vitro and in vivo but
not in Ig-secreting plasma cells (7-11). In the current study, we
address the mechanism by which light chain shifting occurs in some
human plasma cells. To elucidate the intracellular factors involved in
light chain shifting, we tested agents that affect second messenger
pathways, which can induce light chain shifting in the human plasma
cell line HB4C5. Several agents that stimulate protein kinase C,
increase intracellular cAMP and calcium, and inhibit protein kinase A
did not mediate the induction of light chain shifting. We found that
light chain shifting can be induced by caffeine. However, other agents
that also can increase intracellular cAMP concentration, DbcAMP and forskolin, could not induce light chain shifting. Therefore, the induction of light chain shifting is thought to be independent of
intracellular cAMP, and other effect(s) of caffeine should be
considered to be responsible for the induction of the light chain shifting.
Caffeine has pleiotoropic effects in mammalian cells, for example DNA
intercalation and inhibiting poly(ADP-ribose) polymerase, cAMP
phosphodiesterase, and serine/threonine phosphatases (29-31). To test
the possibility that the effect of caffeine on light chain shifting is
due to the inhibition of phosphatase activity, HB4C5 cells were treated
with okadaic acid, which is a serine/threonine phosphatase inhibitor
(32), or vanadate, which is an inhibitor of dual specificity
phosphatase and tyrosine phosphatase (33). Okadaic acid was able to
induce secondary VJ rearrangement in the HB4C5 cells upon stimulation
with a 1 nM dose, which is equivalent to IC50
for type 2A and 4 serine/threonine phosphatase and much lower than type
1 and type 2B (39). Conversely, vanadate was less efficient for the
induction of the VJ recombination. These results suggest that at least
the inhibition of type 2A and/or type 4 serine/threonine protein
phosphatase may play a role in the induction of light chain shifting.
More study is necessary to elucidate how this inhibition affects light
chain shifting in HB4C5 cells. The role of phosphorylation in the
control of recombination has only been shown for the expression of RAG
proteins, which are critical for initiating the V(D)J recombination
(2). RAG-2 protein is marked for degradation upon phosphorylation by p34cdc2 kinase (40). It has been shown that p34cdc2
kinase can be activated by caffeine (41, 42), suggesting that caffeine
may act as an agent in the degradation pathway of RAG-2 protein. In
fact, the expression of RAG proteins was not enhanced in the HB4C5
cells when stimulated with caffeine or okadaic acid. We have previously
shown that the enhancement of RAG gene expression did not induce the
light chain shifting (13). Taken together, these results suggest that
the induction of light chain shifting in plasma cells by caffeine is
not due to an enhancement of the RAG gene expression.
V(D)J recombination of the Ig genes is initiated by the RAG-1 and RAG-2
proteins, which recognize the recombination signal sequences that flank
each V, D, and J segment, to introduce double-stranded DNA breaks
between the gene segments and the recombination signal sequence,
resulting in signal broken ends and coding broken ends (cutting phase).
The joining of recombination signal sequence and coding ends relies on
generally expressed cellular factors involved in DNA double-stranded
break repair (43). RAG gene expression and germ line transcription are
thought to be sufficient enough for activating the cutting phase. Even
though HB4C5 cells do produce the germ line transcript, the expression
level of V
germ line transcript in HB4C5 cells did not
change when stimulated with caffeine or okadaic acid. This suggests
that the occurrence of secondary V
J
rearrangement in this plasma cell line is not a result of up-regulation
of the V
germ line transcription. Although the level of
RAG proteins and V
germ line transcript produced was not
affected by the addition of caffeine or okadaic acid, the amount of
signal broken end at the V
locus as a result of the
action of a V(D)J recombinase clearly increased. This result suggests
that the cutting phase in the rearrangement process can be activated by
caffeine or okadaic acid, and the inability to rearrange the
V
J
region in HB4C5 cells in absence of
these agents may be due the lack of formation of the V
SBE.
These results demonstrate that factor(s) other than the RAG proteins
and the up-regulation of germ line transcription may be involved in the
induction of secondary V
J
rearrangement by caffeine or okadaic acid. The recruitment process for the
recombinase complex to the rearranging locus remains obscure (17). At
least, the increase of V
SBE in HB4C5 cells cultured
with caffeine or okadaic acid may reflect a recruitment of a
recombinase complex to the V
locus. All known stimuli
such as cAMP-raising agents, interleukin-4, and/or lipopolysaccharide,
which trigger V(D)J rearrangement in pre-B and mature B cells, induce
either RAG gene expression or germ line transcription (9-11, 44, 45).
Thus, caffeine may play a unique role in determining other aspects of the initiation mechanism for secondary V
J
rearrangement in human plasma cells.
We observed that SBE is generated at elevated amounts after a 96-h
stimulation time period with caffeine but was barely detected after
24 h. This time lag suggests that stimulation for over 24 h
is needed before change of the chromatin structure at the light chain
locus and/or V(D)J recombinase activation in HB4C5 cells can occur.
This supports the hypothesis that activation of the recruitment
process, which brings the recombinase complex to the V
locus, is regulated by as yet unknown additional factor(s) that may be
up-regulated or activated by the phosphatase inhibitory effect of
caffeine or okadaic acid. Determining such factor(s) will be
informative in elucidating the regulation mechanism for the light chain
shifting in human plasma cells.
The observation that the amount of SBE induced by caffeine is almost
equal to that induced by okadaic acid is not consistent with the
observation that V
J
coding joint
formation induced by caffeine is at a much higher level than that by
okadaic acid. This result suggests that the difference in VJ coding
joint formation between caffeine and okadaic acid may be correlated with the difference in the activity for joining coding ends and may be
mediated by an effect other than phosphatase inhibitory activity of caffeine.
 |
ACKNOWLEDGEMENT |
We thank Perry Seto for proofreading the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by Grant-in-Aid for
Encouragement of Young Scientists and Program for Promotion of Basic
Research Activities for Innovative Biosciences.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. E-mail:
tatibana@agr.kyushu-u.ac.jp.
 |
ABBREVIATIONS |
The abbreviations used are:
ConA, concanavalin
A;
DbcAMP, dibutyryl cAMP;
PMA, phorbol myristate acetate;
vanadate, sodium orthovanadate;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
SBE, signal DNA broken end;
PCR, polymerase chain reaction;
RT, reverse
transcriptase;
LMPCR, ligation-mediated PCR.
 |
REFERENCES |
| 1.
|
Lewis, S. M.
(1994)
Adv. Immunol.
56,
27-150[Medline]
[Order article via Infotrieve]
|
| 2.
|
Oettinger, M. A.,
Schatz, D. G.,
Gorka, C.,
and Baltimore, D.
(1990)
Science
248,
1517-1523[Abstract/Free Full Text]
|
| 3.
|
Schatz, D. G.,
Oettinger, M. A.,
and Baltimore, D.
(1989)
Cell
59,
1035-1048[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Nussenzweig, A.,
Chen, C.,
da Costa Soares, V.,
Sanchez, M.,
Sokol, K.,
Nussenzweig, M. C.,
and Li, G. C.
(1996)
Nature
382,
551-555[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Taccioli, G.,
and Alt, F. W.
(1995)
Curr. Opin. Immunol.
7,
436-440[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Li, Z.,
Otevrel, T.,
Gao, Y.,
Cheng, H.-L.,
Seed, B.,
Stamoto, T. D.,
Taccioli, G. E.,
and Alt, F. W.
(1995)
Cell
83,
1079-1089[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Gay, D.,
Saunders, T.,
Camper, S.,
and Weigert, M.
(1993)
J. Exp. Med.
177,
999-1008[Abstract/Free Full Text]
|
| 8.
|
Tiegs, S.,
Russell, D. M.,
and Nemazee, D.
(1993)
J. Exp. Med.
177,
1009-1020[Abstract/Free Full Text]
|
| 9.
|
Papavasiliou, F.,
Casellas, R.,
Suh, H.,
Qin, X.-F.,
Besmer, E.,
Pelanda, R.,
Nemazee, D.,
Rajewsky, K.,
and Nussenzweig, M. C.
(1997)
Science
278,
298-301[Abstract/Free Full Text]
|
| 10.
|
Han, S.,
Dillon, S. R.,
Zheng, B.,
Shimoda, M.,
Schlissel, M. S.,
and Kelsoe, G.
(1997)
Science
278,
301-305[Abstract/Free Full Text]
|
| 11.
|
Hikida, M.,
and Ohmori, H.
(1998)
J. Exp. Med.
187,
795-799[Abstract/Free Full Text]
|
| 12.
|
Tachibana, H.,
Kido, I.,
and Murakami, H.
(1994)
J. Biol. Chem.
269,
29061-29066[Abstract/Free Full Text]
|
| 13.
|
Tachibana, H.,
Ushio, Y.,
Chatchadaporn, K.,
and Shirahata, S.
(1996)
J. Biol. Chem.
271,
17404-17410[Abstract/Free Full Text]
|
| 14.
|
Tachibana, H.,
Haruta, H.,
and Yamada, K.
(1999)
Blood
93,
198-207[Abstract/Free Full Text]
|
| 15.
|
Yancopoulos, G.,
Blackwell, T.,
Suh, H.,
Hood, L.,
and Alt, F. W.
(1986)
Cell
44,
251-259[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Stanhope-Baker, P.,
Hudson, K. M.,
Shaffer, A. L.,
Constantinescu, A.,
and Schlissel, M. S.
(1996)
Cell
85,
887-897[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Constantinescu, A.,
and Schlissel, M. S.
(1997)
J. Exp. Med.
185,
609-620[Abstract/Free Full Text]
|
| 18.
|
Yancopoulos, G. D,
and Alt, F. W.
(1985)
Cell
40,
271-281[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Schlissel, M. S.,
Corcoran, L. M.,
and Baltimore, D.
(1991)
J. Exp. Med.
173,
711-720[Abstract/Free Full Text]
|
| 20.
|
Schlissel, M. S.,
and Morrow, T.
(1994)
J. Immunol.
153,
1645-1657[Abstract]
|
| 21.
|
Murakami, H.,
Hashizume, S.,
Ohashi, H.,
Shinohara, K.,
Yasumoto, K.,
Nomoto, K.,
and Omura, H.
(1985)
In Vitro Cell. Dev. Biol.
21,
593-596[Medline]
[Order article via Infotrieve]
|
| 22.
|
Kato, M.,
Mochizuki, K.,
Kuroda, K.,
Sato, S.,
Murakami, H.,
Yasumoto, K.,
Nomoto, K.,
and Hashizume, S.
(1991)
Hum. Antibod. Hybridomas
2,
94-101[Medline]
[Order article via Infotrieve]
|
| 23.
|
Larrick, J. W.,
Danielsson, L.,
Brenner, C. A.,
Wallace, E. F.,
Abrahamson, M.,
Fry, K. E.,
and Borrebaeck, C. A. K.
(1989)
Bio/Technology
7,
934-938[CrossRef]
|
| 24.
|
Schlissel, M. S.,
Constantinescu, A.,
Morrow, T.,
Baxter, M.,
and Peng, A.
(1993)
Genes Dev.
7,
2520-2532[Abstract/Free Full Text]
|
| 25.
|
Ohta, S.,
Inazu, T.,
Taniguchi, T.,
Nagata, G.,
and Yamamura, H.
(1992)
Eur. J. Biochem.
206,
895-900[Medline]
[Order article via Infotrieve]
|
| 26.
|
Wenzel-Seifert, K.,
Krautwurst, D.,
Lentzen, H.,
and Seifert, R.
(1996)
J. Leukoc. Biol.
60,
345-355[Abstract]
|
| 27.
|
Chuchana, P.,
Blancher, A.,
Brockly, F.,
Alexandre, D.,
Lefranc, G.,
and Lefranc, M.-P.
(1990)
Eur. J. Immunol.
20,
1317-1325[Medline]
[Order article via Infotrieve]
|
| 28.
|
Williams, S. C.,
Frippiat, J.-P.,
Tomlinson, I. M.,
Ignatovich, O.,
Lefranc, M.-P.,
and Winter, G.
(1996)
J. Mol. Biol.
264,
220-232[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Tornaletti, S.,
Russo, P.,
Parodi, S.,
and Pedrini, A. M.
(1989)
Biochim. Biophys. Acta
1007,
112-115[Medline]
[Order article via Infotrieve]
|
| 30.
|
Lock, R. B.,
Galperina, O. V.,
Feldhoff, R. C.,
and Rhodes, L. J.
(1994)
Cancer Res.
54,
4933-4939[Abstract/Free Full Text]
|
| 31.
|
Butcher, R. W.,
and Sutherland, E. W.
(1962)
J. Biol. Chem.
237,
1244-1250[Free Full Text]
|
| 32.
|
Thevenin, C.,
Kim, S.-J.,
and Kehrl, J. H.
(1991)
J. Biol. Chem.
266,
9363-9366[Abstract/Free Full Text]
|
| 33.
|
Gordon, J. A.
(1991)
Methods Enzymol.
201,
477-482[Medline]
[Order article via Infotrieve]
|
| 34.
|
Schlissel, M. S.,
and Baltimore, D.
(1989)
Cell
58,
1001-1007[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Wang, W.,
Rath, S.,
Durdik, J. M.,
and Sen, R.
(1998)
J. Immunol.
160,
1789-1795[Abstract/Free Full Text]
|
| 36.
|
Rajewsky, K.
(1996)
Nature
381,
751-753[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Ramsden, D. A.,
and Gellert, M.
(1995)
Genes Dev.
9,
2409-2420[Abstract/Free Full Text]
|
| 38.
|
Roth, D. B.,
Menetski, J. P.,
Nakajima, P. B.,
Bosma, M. J.,
and Gellert, M.
(1992)
Cell
70,
983-991[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Hunter, T.
(1995)
Cell
80,
225-236[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Lin, W. C.,
and Desiderio, S.
(1993)
Science
260,
953-959[Abstract/Free Full Text]
|
| 41.
|
Hains, J.,
Crompton, N. E. A.,
Burkar, W.,
and Jaussi, R.
(1993)
Cancer Res.
53,
1507-1510[Abstract/Free Full Text]
|
| 42.
|
Yao, S.-L.,
Akhtar, A. J.,
McKenna, K. A.,
Bedi, G. C.,
Sidransky, D.,
Mabry, M.,
Ravi, R.,
Collector, M. I.,
Jones, R. J,
Sharkis, S. J.,
Fuchs, E. J.,
and Bedi, A.
(1996)
Nat. Med.
2,
1140-1143[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Weaver, D. T.,
and Alt, F. W.
(1997)
Nature
388,
428-429[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Menetski, J.,
and Gellert, M.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
9324-9328[Abstract/Free Full Text]
|
| 45.
|
Hertz, M.,
Kouskoff, V.,
Nakamura, T.,
and Nemazee, D.
(1998)
Nature
394,
292-295[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.